Mufazalova N A, Treshchalin I D, Treshchalina E M, Sedakova L A, Andronova N V
Department of Pharmacology No. 1, Course of Clinical Pharmacology, Bashkirian State Medical University, Ufa.
Bull Exp Biol Med. 2004 Jan;137(1):37-9. doi: 10.1023/b:bebm.0000024381.69886.45.
We studied the effect of combination treatment with T-activin and vitamin E on acute toxicity and antitumor activity of cyclophosphamide in mice. Combined administration of these preparations 1.37-fold increased the maximum permissible dose of cyclophosphamide without affecting its LD(50)and delayed mouse death from cyclophosphamide toxicity. Most mice died only 3 days after combination treatment with the test preparations and cyclophosphamide in doses of LD(16)-LD(84). The second peak of death from hematologic toxicity of cyclophosphamide was absent under these conditions. T-activin and vitamin E did not abolish the antitumor effect of cyclophosphamide on mice with subcutaneously implanted P-388 lympholeukemia. Tumor growth was suppressed by 100%.
我们研究了T-激活素与维生素E联合治疗对环磷酰胺在小鼠体内急性毒性和抗肿瘤活性的影响。联合使用这些制剂使环磷酰胺的最大耐受剂量增加了1.37倍,而不影响其半数致死量(LD50),并延迟了小鼠因环磷酰胺毒性而死亡的时间。在用试验制剂与环磷酰胺按LD16 - LD84剂量联合治疗后,大多数小鼠仅在3天后死亡。在这些条件下,环磷酰胺血液学毒性导致的第二个死亡高峰未出现。T-激活素和维生素E并未消除环磷酰胺对皮下植入P-388淋巴细胞白血病小鼠的抗肿瘤作用。肿瘤生长受到100%抑制。